• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[骨质疏松相关性髋关节炎的人工关节置换治疗:患者安全治疗的相关方面]

[Endoprosthetic treatment of osteoporosis-related coxarthrosis : aspects of safe patient treatment].

作者信息

Kirschner S, Hartmann A, Günther K-P, Hamann C

机构信息

UniversitätsCentrum für Orthopädie und Unfallchirurgie, Universitätsklinikum Carl-Gustav Carus, Technische Universität Dresden AöR, Fetscherstr. 74, 01307, Dresden, Deutschland,

出版信息

Orthopade. 2014 Apr;43(4):353-64. doi: 10.1007/s00132-013-2167-0.

DOI:10.1007/s00132-013-2167-0
PMID:24664134
Abstract

BACKGROUND

With increasing life expectancy the prevalence of osteoarthritis is also substantially rising. Patients aged between 65 and 75 years scheduled for total joint arthroplasty suffer from undetected osteoporosis in 20-25% of cases.

OBJECTIVES

How to determine osteoporosis during preoperative workup? Which conclusions can be drawn for the operation treatment and the postoperative course?

METHODS

The literature dealing with the prevalence of osteoporosis, perioperative complications of total hip arthroplasty, selected register informations, guidelines for diagnostics and treatment of osteoporosis and for the postoperative treatment are summarized and discussed.

RESULTS

The fracture risk is determined according to the guidelines of the Dachverband Osteologie (DVO, Governing Body on Osteology). The implant and the anchorage are selected based on the risk of suffering from osteoporosis. An intraoperative fracture and early aseptic loosening are the main operative risk factors. For the postoperative course in addition to education about arthroplasty, adequate support for prevention of falls is mandatory. Continuous physiotherapy with muscular strengthening is advisable. The long-term medication should be checked for risks in the PRISCUS list of potentially inappropriate medication in the elderly and non-steroidal anti-inflammatory drugs (NSAIDs) should not be prescribed in patients with cardiac comorbidities. Patients with confirmed osteoporosis should be treated with antiresorptive agents.

摘要

背景

随着预期寿命的增加,骨关节炎的患病率也在大幅上升。计划进行全关节置换术的65至75岁患者中,有20%至25%的病例存在未被检测出的骨质疏松症。

目的

如何在术前检查中确定骨质疏松症?对于手术治疗和术后病程可以得出哪些结论?

方法

总结并讨论了有关骨质疏松症患病率、全髋关节置换术围手术期并发症、选定的登记信息、骨质疏松症诊断和治疗指南以及术后治疗的文献。

结果

根据德国骨科学会(DVO,骨科学管理机构)的指南确定骨折风险。根据骨质疏松症患病风险选择植入物和固定方式。术中骨折和早期无菌性松动是主要的手术风险因素。对于术后病程,除了进行关节置换术相关教育外,必须提供足够的预防跌倒支持。建议持续进行增强肌肉的物理治疗。应检查长期用药是否存在老年潜在不适当用药PRISCUS列表中的风险,对于有心脏合并症的患者不应开具非甾体抗炎药(NSAIDs)。确诊为骨质疏松症的患者应使用抗吸收药物进行治疗。

相似文献

1
[Endoprosthetic treatment of osteoporosis-related coxarthrosis : aspects of safe patient treatment].[骨质疏松相关性髋关节炎的人工关节置换治疗:患者安全治疗的相关方面]
Orthopade. 2014 Apr;43(4):353-64. doi: 10.1007/s00132-013-2167-0.
2
[New DVO guideline for osteoporosis management 2014 and its importance for trauma surgeons].[2014年骨质疏松症管理新的DVO指南及其对创伤外科医生的重要性]
Unfallchirurg. 2015 Nov;118(11):905-12. doi: 10.1007/s00113-015-0070-3.
3
[Identification, diagnostics and guideline conform therapy of osteoporosis (DVO) in trauma patients : a treatment algorithm].创伤患者骨质疏松症(DVO)的识别、诊断及指南遵循治疗:一种治疗算法
Unfallchirurg. 2015 Nov;118(11):913-24. doi: 10.1007/s00113-015-0071-2.
4
[Diagnosing osteoporosis: what is new in the 2014 DVO guideline?].[诊断骨质疏松症:2014年美国骨矿研究学会指南中有哪些新内容?]
Dtsch Med Wochenschr. 2015 Nov;140(22):1667-71. doi: 10.1055/s-0041-103417. Epub 2015 Nov 4.
5
Effects of anti-osteoporosis medications on total hip arthroplasty risks in osteoporotic patients with hip osteoarthritis in Taiwan: a nationwide cohort study.台湾地区骨质疏松性髋关节炎伴骨质疏松症患者抗骨质疏松药物对全髋关节置换术风险的影响:一项全国性队列研究。
Arch Osteoporos. 2018 Oct 10;13(1):107. doi: 10.1007/s11657-018-0522-9.
6
Association of Bisphosphonate Use and Risk of Revision After THA: Outcomes From a US Total Joint Replacement Registry.双膦酸盐使用与全髋关节置换术后翻修风险的关联:来自美国全关节置换登记处的结果
Clin Orthop Relat Res. 2015 Nov;473(11):3412-20. doi: 10.1007/s11999-015-4263-4.
7
[New strategies for exercise training in osteoporosis].[骨质疏松症运动训练的新策略]
Unfallchirurg. 2015 Nov;118(11):933-7. doi: 10.1007/s00113-015-0080-1.
8
[Total hip replacement: a criterion of coxarthrosis evaluation?].
Rev Prat. 2002 Mar 1;52(5 Suppl):S11-3.
9
[Operative treatment of congenital hip osteoarthritis with high hip luxation (Crowe type IV)].先天性髋关节骨关节炎伴高位髋关节脱位(克劳氏IV型)的手术治疗
Oper Orthop Traumatol. 2013 Oct;25(5):469-82. doi: 10.1007/s00064-013-0241-8. Epub 2013 Oct 2.
10
Osteoarthritis.骨关节炎
Clin Evid. 2002 Jun(7):1071-90.

引用本文的文献

1
[Characteristics of elective hip replacement in the elderly].[老年人择期髋关节置换的特点]
Orthopade. 2017 Jan;46(1):25-33. doi: 10.1007/s00132-016-3364-4.

本文引用的文献

1
90-day mortality after 409,096 total hip replacements for osteoarthritis, from the National Joint Registry for England and Wales: a retrospective analysis.英格兰和威尔士国家关节登记处对 409096 例骨关节炎全髋关节置换术后 90 天死亡率的回顾性分析。
Lancet. 2013 Sep 28;382(9898):1097-104. doi: 10.1016/S0140-6736(13)61749-3.
2
Deconstructing vitamin D deficiency.解析维生素 D 缺乏症。
Sci Transl Med. 2013 Jul 10;5(193):193fs27. doi: 10.1126/scitranslmed.3006566.
3
A meta-analysis of bisphosphonates for periprosthetic bone loss after total joint arthroplasty.
双膦酸盐用于全关节置换术后假体周围骨丢失的荟萃分析。
J Orthop Sci. 2013 Sep;18(5):762-73. doi: 10.1007/s00776-013-0411-4. Epub 2013 Jun 1.
4
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.非甾体抗炎药的血管和上消化道作用:来自随机试验的个体参与者数据的荟萃分析。
Lancet. 2013 Aug 31;382(9894):769-79. doi: 10.1016/S0140-6736(13)60900-9. Epub 2013 May 30.
5
[Prevalence of selected musculoskeletal conditions in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)].[德国特定肌肉骨骼疾病的患病率:德国成人健康访谈与检查调查(DEGS1)结果]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):678-86. doi: 10.1007/s00103-013-1687-4.
6
WITHDRAWN: Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty.撤回:用于预防髋关节置换术后异位骨化的非甾体类抗炎药。
Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD001160. doi: 10.1002/14651858.CD001160.pub3.
7
Acetabular components in total hip arthroplasty: is there evidence that cementless fixation is better?全髋关节置换术中的髋臼部件:有无证据表明非骨水泥固定更好?
J Bone Joint Surg Am. 2013 Jan 16;95(2):168-74. doi: 10.2106/JBJS.K.01652.
8
Risk factors for revision of primary total hip arthroplasty: a systematic review.初次全髋关节置换翻修的风险因素:系统评价。
BMC Musculoskelet Disord. 2012 Dec 15;13:251. doi: 10.1186/1471-2474-13-251.
9
Interventions for preventing falls in older people in care facilities and hospitals.护理机构和医院中预防老年人跌倒的干预措施。
Cochrane Database Syst Rev. 2012 Dec 12;12:CD005465. doi: 10.1002/14651858.CD005465.pub3.
10
Effect of zoledronic acid on reducing femoral bone mineral density loss following total hip arthroplasty: preliminary results of a prospective randomized trial.唑来膦酸对全髋关节置换术后股骨骨密度丢失的影响:一项前瞻性随机试验的初步结果。
J Arthroplasty. 2013 Apr;28(4):671-5. doi: 10.1016/j.arth.2012.08.007. Epub 2012 Nov 8.